Delivery Order SPE2DB22D2009-SPE2DB25FM0SR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units under a firm fixed-price contract valued at $2,958.36. This non-set-aside delivery order is set for completion by July 17, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units, with a ceiling value of $1,160.93. This firm fixed-price delivery order is set to be completed by December 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded transaction under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $5,354.10, is due for completion by July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical...
- The Defense Logistics Agency awarded a $2,984.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ibuprofen 800 mg, with a completion date of December 5, 2025. This non-set-aside contract was competitively awarded and represents a direct fulfillment order under AmerisourceBergen's existing federal pharmaceutical supply agreements. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,024.35 to AmerisourceBergen Drug Corp for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. This non-competitive, firm fixed-price delivery order was awarded on December 17, 2025, with an ultimate completion date of December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ibuprofen 400 mg, with a ceiling value of $1,066.72. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 19, 2025. The award was issued on December 18, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 count bottles of 800 milligram Ibuprofen tablets, with a ceiling value of $1,561.49 and a performance period ending on July 2, 2025. The award is not set aside and was made on July 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $19,652.71 delivery order to AmerisourceBergen Drug Corp for Ibuprofen 200 mg capsules (30-count) with a completion date of December 26, 2025. This contract, awarded December 4, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- This is a $1,265.26 delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ibuprofen 600 mg tablets in 100-count bottles, with a performance period ending on June 9, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $692.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 count bottles of 800 mg ibuprofen tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by August 21, 2023 in support of the Department of Defense's medical supply needs. Amerisourcebergen will serve as the prime...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0SRDelivery Order
The Defense Logistics Agency awarded a $1,607.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. The contract, which represents a child award under a larger indefinite delivery vehicle, is scheduled for completion by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded in the open market. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999.99 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX) through December 2026, which serves as the parent vehicle for this delivery order. As a critical vendor in the federal medical procurement supply chain, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply requirements across the Defense Health Agency and broader Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/6/25 |